Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,033 | 1,070 | 1,139 | 781 | 929 |
| Cost of Goods | 479 | 508 | 510 | 471 | 659 |
| Gross Profit | 554 | 562 | 628 | 310 | 270 |
| Operating Expenses | 4,842 | 5,156 | 5,860 | 4,851 | 5,966 |
| Operating Income | -4,288 | -4,594 | -5,232 | -4,542 | -5,697 |
| Interest Expense | 24 | 30 | 21 | 5 | 10 |
| Other Income | 56 | 54 | 17 | 136 | 108 |
| Pre-tax Income | -4,256 | -4,571 | -5,235 | -4,411 | -5,599 |
| Net Income Continuous | -4,256 | -4,571 | -5,235 | -4,411 | -5,599 |
| Net Income | $-4,256 | $-4,571 | $-5,235 | $-4,411 | $-5,599 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.03 | -0.02 | -0.03 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.03 | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.03 | -0.02 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.03 | -0.02 | -0.03 |
| EBITDA(a) | $-3,960 | $-4,254 | $-4,901 | $-4,130 | $-5,317 |